Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 49
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2401 | JIANGSU FLAG CHEMICAL INDUSTRY | 6 | 00% | 0 | 6 | 2023–2025 |
| 2402 | JILIN ZHONG YING HIGH TECHNOLOGY | 6 | 233.3% | 0 | 4 | 2022–2024 |
| 2403 | JNANA THERAPEUTICS | 6 | 00% | 0 | 6 | 2022–2026 |
| 2404 | JOHN BEAN TECHNOLOGIES | 6 | 00% | 0 | 6 | 2023–2025 |
| 2405 | JOHNSON JOHNSON VISION CARE | 6 | 00% | 0 | 6 | 2022–2024 |
| 2406 | JOHNSON SCREENS | 6 | 00% | 0 | 6 | 2023–2026 |
| 2407 | KAI R D CENTER | 6 | 233.3% | 0 | 4 | 2022–2026 |
| 2408 | KALIVIR IMMUNOTHERAPEUTICS | 6 | 00% | 0 | 6 | 2023–2025 |
| 2409 | KANADEVIA | 6 | 00% | 0 | 6 | 2025–2026 |
| 2410 | KANAPH THERAPEUTICS | 6 | 00% | 0 | 6 | 2023–2025 |
| 2411 | KDDI | 6 | 350% | 1 | 2 | 2023–2025 |
| 2412 | KEIWA | 6 | 00% | 1 | 5 | 2022–2024 |
| 2413 | KEYGENE | 6 | 00% | 0 | 6 | 2022–2025 |
| 2414 | KINAXIS | 6 | 00% | 5 | 1 | 2022–2024 |
| 2415 | KINDRED BIOSCIENCES | 6 | 00% | 1 | 5 | 2022–2023 |
| 2416 | KOKUYO | 6 | 00% | 0 | 6 | 2022–2025 |
| 2417 | KOMAX HOLDING | 6 | 350% | 0 | 3 | 2022–2025 |
| 2418 | KOREA KUMHO PETROCHEMICAL | 6 | 466.7% | 0 | 2 | 2022–2024 |
| 2419 | KYOKUTOH | 6 | 116.7% | 1 | 4 | 2022–2024 |
| 2420 | L B OFFICINE MECCANICHE | 6 | 00% | 0 | 6 | 2023–2023 |
| 2421 | LAMIFLEX GROUP | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2422 | LANOVA MEDICINES | 6 | 00% | 0 | 6 | 2022–2025 |
| 2423 | LINA ENERGY | 6 | 00% | 1 | 5 | 2023–2026 |
| 2424 | LINEAGE LOGISTICS | 6 | 00% | 3 | 3 | 2023–2024 |
| 2425 | LINXENS HOLDING | 6 | 233.3% | 0 | 4 | 2020–2025 |
| 2426 | LMI TECHNOLOGIES | 6 | 00% | 0 | 6 | 2023–2025 |
| 2427 | LOCKHEED MARTIN | 6 | 233.3% | 0 | 4 | 2022–2025 |
| 2428 | LOCKHEED MARTIN ENERGY | 6 | 00% | 0 | 6 | 2023–2024 |
| 2429 | LS CABLE SYSTEM | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2430 | LTS LOHMANN THERAPIE SYSTEME | 6 | 233.3% | 3 | 1 | 2022–2024 |
| 2431 | MAGNAX | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2432 | MAGNERA | 6 | 00% | 0 | 6 | 2025–2026 |
| 2433 | MAGNUM IP HOLDINGS | 6 | 00% | 0 | 6 | 2025–2026 |
| 2434 | MARLOW FOODS | 6 | 00% | 1 | 5 | 2022–2025 |
| 2435 | MATHERS HYDRAULICS TECHNOLOGIES PTY | 6 | 00% | 0 | 6 | 2022–2025 |
| 2436 | MAZE THERAPEUTICS | 6 | 00% | 1 | 5 | 2023–2026 |
| 2437 | MBDA FRANCE | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2438 | MEIRAGTX UK II | 6 | 00% | 2 | 4 | 2022–2024 |
| 2439 | METS SPRING | 6 | 00% | 0 | 6 | 2023–2024 |
| 2440 | MILLENNIUM PHARMACEUTICALS | 6 | 00% | 1 | 5 | 2022–2023 |
| 2441 | MIROMATRIX MEDICAL | 6 | 00% | 0 | 6 | 2023–2026 |
| 2442 | MITSUBISHI CHEMICAL UK | 6 | 00% | 3 | 3 | 2022–2026 |
| 2443 | MITSUBISHI HEAVY INDUSTRIES ENVIRONMENTAL CHEMICAL ENGINEERING | 6 | 466.7% | 0 | 2 | 2023–2023 |
| 2444 | MITSUI CHEMICALS ASAHI LIFE MATERIALS | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2445 | MODULEUS | 6 | 00% | 0 | 6 | 2022–2024 |
| 2446 | MONTEFIBRE MAE TECHNOLOGIES S R L | 6 | 00% | 0 | 6 | 2022–2025 |
| 2447 | MORESCO | 6 | 350% | 0 | 3 | 2022–2025 |
| 2448 | MOXIETEC | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2449 | MU IONIC SOLUTIONS | 6 | 583.3% | 0 | 1 | 2022–2025 |
| 2450 | MURRELEKTRONIK | 6 | 00% | 0 | 6 | 2025–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →